Contact Us
Messenger Ribonucleic Acid (mRNA) Capping Enzyme Global Market Report 2025
Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Global Market Report 2025

By Product Type (Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes); By Application (Research And Development, Therapeutics, Diagnostics, Other Applications); By End-User (Pharmaceutical And Biotechnology Companies, Research Institutions, Contract Manufacturing Organizations (CMOS)); Subsegments:; By Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes (Vaccinia Capping Enzyme (VCE), RNA Triphosphatase, Guanylyltransferase, (Guanine-N7)-Methyltransferase); By Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes (Cap 0 Capping Enzymes, Cap 1 Capping Enzymes, Cap 2 Capping Enzymes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

• Messenger Ribonucleic Acid (mRNA) Capping Enzyme market size has reached to $0.89 billion in 2024

• Expected to grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%

• Growth Driver: Rising Adoption Of Personalized Medicine Driving Growth Of The Market Due To Advances In Genetic Testing And Targeted Therapies

• Market Trend: Innovative Enzyme Solutions Enhancing mRNA Capping Efficiency And Simplifying Production Processes

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?

Messenger ribonucleic acid (mRNA) capping enzyme is a vital enzyme that modifies newly synthesized mRNA molecules in eukaryotic cells. It adds a special chemical structure called the 5' cap to the beginning of the mRNA strand soon after it is transcribed from DNA. This capping step involves attaching a modified guanine nucleotide to the mRNA through an unusual 5’-5’ linkage.

The main product types of messenger ribonucleic acid (mRNA) capping enzymes include recombinant messenger ribonucleic acid (mRNA) capping enzymes and natural messenger ribonucleic acid (mRNA) capping enzymes. Recombinant mRNA capping enzymes are genetically engineered proteins that selectively catalyze the capping of RNA molecules. It is applied for research and development, therapeutics, diagnostics, and others by several end-users, including pharmaceutical and biotechnology companies, research institutions, and contract manufacturing organizations (CMOs).

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Size and growth rate 2025 to 2029: Graph

What Is The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Size 2025 And Growth Rate?

The messenger ribonucleic acid (mRNA) capping enzyme market size has grown rapidly in recent years. It will grow from $0.89 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to growth of molecular biology and biotechnology research, expansion of genetic engineering and synthetic biology, rising applications in vaccine research, increasing government and private funding for RNA research, and growth of biopharmaceutical manufacturing.

What Is The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Growth Forecast?

The messengerribonucleic acid (mRNA) capping enzyme market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising investment in RNA-based drug development, growing pipeline of mRNA-based clinical trials, expansion of personalized and precision medicine, increasing focus on stability and translational efficiency of mRNA, and increasing adoption of mRNA vaccines and therapeutics. Major trends in the forecast period include integration with artificial intelligence and machine learning, development of in-vitro transcription (IVT) technologies, development of next-generation enzymatic capping systems, advancements in synthetic cap analogs and co-transcriptional capping technologies, and innovation in enzyme design.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Segmented?

1) By Product Type: Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes

2) By Application: Research And Development, Therapeutics, Diagnostics, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutions, Contract Manufacturing Organizations (CMOS)

Subsegments:

1) By Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Vaccinia Capping Enzyme (VCE), RNA Triphosphatase, Guanylyltransferase, (Guanine-N7)-Methyltransferase

2) By Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Cap 0 Capping Enzymes, Cap 1 Capping Enzymes, Cap 2 Capping Enzymes

What Is Driving The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market? Rising Adoption Of Personalized Medicine Driving Growth Of The Market Due To Advances In Genetic Testing And Targeted Therapies

The growing adoption of personalized medicine is expected to propel the growth of the messenger ribonucleic acid (mRNA) capping enzyme market going forward. Personalized medicine is a healthcare approach that customizes medical treatment based on a person’s unique genetic makeup, lifestyle, and environmental influences. The adoption of personalized medicine is rising due to advancements in genetic testing technologies, which enable more accurate identification of individual patient needs, allowing for targeted and effective treatments. mRNA capping enzymes are beneficial for personalized medicines as they improve the stability and proper function of therapeutic mRNA, ensuring it is efficiently translated into proteins tailored to an individual’s treatment needs. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, marking a significant increase from six approvals in 2022. Therefore, the growing adoption of personalized medicine is driving the growth of the messenger ribonucleic acid (mRNA) capping enzyme industry.

Who Are The Major Players In The Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?

Major companies operating in the messenger ribonucleic acid (mrna) capping enzyme market are Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Takara Bio Inc., Aldevron, New England Biolabs Inc., CellScript Inc., Krishgen Biosystems, Yeasen Biotechnology Co. Ltd., Novoprotein Scientific Inc., TriLink Biotechnologies LLC, Jena Bioscience GmbH, OZ Biosciences, SBS Biotech Ltd., Vazyme Biotech Co. Ltd., Enzynomics Inc., Creative Enzymes, Canvax Biotech SL, APExBIO Technology LLC, BOC Sciences, KACTUS Biosystems.

What Are The Key Trends Of The Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market? Innovative Enzyme Solutions Enhancing mRNA Capping Efficiency And Simplifying Production Processes

Major companies operating in the messenger ribonucleic acid (mRNA) capping enzyme market are focusing on developing advanced solutions, such as broad temperature mRNA capping solutions, to simplify logistics by eliminating the need for strict cold chain storage. Broad temperature mRNA capping solutions are designed to keep mRNA capping enzymes stable and effective at various temperatures, supporting their use in different storage and treatment conditions. For instance, in August 2022, New England Biolabs, a US-based life sciences company, launched the Faustovirus Capping Enzyme (FCE), a breakthrough enzymatic tool designed to overcome limitations of traditional capping methods in mRNA production. It features a single-subunit structure that combines RNA triphosphatase, guanylyltransferase, and N7-guanine methyltransferase activities in one enzyme. It provides broad temperature stability, functioning effectively from 20°C to 55°C, which allows greater flexibility in reaction conditions. The system uses a novel viral enzyme platform to produce Cap-0 structures and enables easy one-pot synthesis of Cap-1 structures when used together with NEB’s 2'-O-methyltransferase. This solution integrates smoothly into current mRNA production workflows, offering high capping efficiency, reducing enzyme use by up to half compared to traditional methods, and removing the need for harmful organic solvents.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market? Mapmygenome Expands Microbiome Capabilities With Microbiome Insights Acquisition

In February 2025, TriLink BioTechnologies, a US-based biotechnology company, partnered with Aldevron to integrate CleanCap mRNA capping technology into Aldevron’s mRNA development and manufacturing services. Through this partnership, Aldevron aims to enhance mRNA yield, accelerate processing, and deliver higher-quality therapeutic solutions by leveraging TriLink’s CleanCap analogs, including CleanCap M6, AG 3'OMe, AG, and AU, which provide over 95% capping efficiency and improved expression levels. Aldevron is a US-based contract development and manufacturing organization (CDMO).

What Is The Regional Outlook For The Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?

North America was the largest region in the messenger ribonucleic acid (mRNA) capping enzyme market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?

The messenger ribonucleic acid (mRNA) capping enzyme market consists of sales of inorganic pyrophosphatase, murine RNase inhibitor, and polymerase chain reaction enzymes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Messenger Ribonucleic Acid (mRNA) Capping Enzyme Industry?

The messenger ribonucleic acid (mrna) capping enzyme market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) capping enzyme industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Table Of Contents

1. Executive Summary

2. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Characteristics

3. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Trends And Strategies

4. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Growth Analysis And Strategic Analysis Framework

5.1. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Growth Rate Analysis

5.4. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Total Addressable Market (TAM)

6. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Segmentation

6.1. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes

Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes

6.2. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research And Development

Therapeutics

Diagnostics

Other Applications

6.3. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Research Institutions

Contract Manufacturing Organizations (CMOS)

6.4. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccinia Capping Enzyme (VCE)

RNA Triphosphatase

Guanylyltransferase

(Guanine-N7)-Methyltransferase

6.5. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cap 0 Capping Enzymes

Cap 1 Capping Enzymes

Cap 2 Capping Enzymes

7. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Regional And Country Analysis

7.1. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

8.1. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

9.1. China Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

9.2. China Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

10.1. India Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

11.1. Japan Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

11.2. Japan Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

12.1. Australia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

13.1. Indonesia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

14.1. South Korea Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

14.2. South Korea Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

15.1. Western Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

15.2. Western Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

16.1. UK Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

17.1. Germany Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

18.1. France Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

19.1. Italy Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

20.1. Spain Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

21.1. Eastern Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

21.2. Eastern Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

22.1. Russia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

23.1. North America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

23.2. North America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

24.1. USA Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

24.2. USA Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

25.1. Canada Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

25.2. Canada Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

26.1. South America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

26.2. South America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

27.1. Brazil Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

28.1. Middle East Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

28.2. Middle East Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

29.1. Africa Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Overview

29.2. Africa Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Competitive Landscape And Company Profiles

30.1. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Competitive Landscape

30.2. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Company Profiles

30.2.1. Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Aldevron Overview, Products and Services, Strategy and Financial Analysis

31. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Other Major And Innovative Companies

31.1. New England Biolabs Inc.

31.2. CellScript Inc.

31.3. Krishgen Biosystems

31.4. Yeasen Biotechnology Co. Ltd.

31.5. Novoprotein Scientific Inc.

31.6. TriLink Biotechnologies LLC

31.7. Jena Bioscience GmbH

31.8. OZ Biosciences

31.9. SBS Biotech Ltd.

31.10. Vazyme Biotech Co. Ltd.

31.11. Enzynomics Inc.

31.12. Creative Enzymes

31.13. Canvax Biotech SL

31.14. APExBIO Technology LLC

31.15. BOC Sciences

32. Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

34. Recent Developments In The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market

35. Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market High Potential Countries, Segments and Strategies

35.1 Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market In 2029 - Countries Offering Most New Opportunities

35.2 Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market In 2029 - Segments Offering Most New Opportunities

35.3 Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Roche AG Financial Performance
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Merck KGaA Financial Performance
  • Table 79: Takara Bio Inc. Financial Performance
  • Table 80: Aldevron Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Sub-Segmentation Of Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Roche AG Financial Performance
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Merck KGaA Financial Performance
  • Figure 79: Takara Bio Inc. Financial Performance
  • Figure 80: Aldevron Financial Performance

Frequently Asked Questions

Messenger ribonucleic acid (mRNA) capping enzyme is a vital enzyme that modifies newly synthesized mRNA molecules in eukaryotic cells. It adds a special chemical structure called the 5' cap to the beginning of the mRNA strand soon after it is transcribed from DNA. This capping step involves attaching a modified guanine nucleotide to the mRNA through an unusual 5’-5’ linkage. For further insights on this market, request a sample here

The market major growth driver - Rising Adoption Of Personalized Medicine Driving Growth Of The Market Due To Advances In Genetic Testing And Targeted Therapies. For further insights on this market, request a sample here

The messenger ribonucleic acid (mRNA) capping enzyme market size has grown rapidly in recent years. It will grow from $0.89 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to growth of molecular biology and biotechnology research, expansion of genetic engineering and synthetic biology, rising applications in vaccine research, increasing government and private funding for RNA research, and growth of biopharmaceutical manufacturing. The messenger ribonucleic acid (mRNA) capping enzyme market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising investment in RNA-based drug development, growing pipeline of mRNA-based clinical trials, expansion of personalized and precision medicine, increasing focus on stability and translational efficiency of mRNA, and increasing adoption of mRNA vaccines and therapeutics. Major trends in the forecast period include integration with artificial intelligence and machine learning, development of in-vitro transcription (IVT) technologies, development of next-generation enzymatic capping systems, advancements in synthetic cap analogs and co-transcriptional capping technologies, and innovation in enzyme design. For further insights on this market, request a sample here

The messenger ribonucleic acid (mRNA) capping enzyme market covered in this report is segmented as
1) By Product Type: Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes
2) By Application: Research And Development, Therapeutics, Diagnostics, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutions, Contract Manufacturing Organizations (CMOS) Subsegments:
1) By Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Vaccinia Capping Enzyme (VCE), RNA Triphosphatase, Guanylyltransferase, (Guanine-N7)-Methyltransferase
2) By Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Cap 0 Capping Enzymes, Cap 1 Capping Enzymes, Cap 2 Capping Enzymes For further insights on this market,
request a sample here

North America was the largest region in the messenger ribonucleic acid (mRNA) capping enzyme market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in messenger ribonucleic acid (mRNA) capping enzyme report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the messenger ribonucleic acid (mrna) capping enzyme market are Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Takara Bio Inc., Aldevron, New England Biolabs Inc., CellScript Inc., Krishgen Biosystems, Yeasen Biotechnology Co. Ltd., Novoprotein Scientific Inc., TriLink Biotechnologies LLC, Jena Bioscience GmbH, OZ Biosciences, SBS Biotech Ltd., Vazyme Biotech Co. Ltd., Enzynomics Inc., Creative Enzymes, Canvax Biotech SL, APExBIO Technology LLC, BOC Sciences, KACTUS Biosystems. For further insights on this market, request a sample here.

Major trends in this market include Innovative Enzyme Solutions Enhancing mRNA Capping Efficiency And Simplifying Production Processes For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon